hydralazine has been researched along with Chronic Kidney Failure in 44 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| " After 10 weeks of treatment with benidipine (1, 3, and 5 mg/kg body weight, p." | 3.70 | Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis. ( Kawachi, H; Nakamura, T; Obata, JE; Onitsuka, M; Shimada, Y; Shimizu, F; Yoshida, Y, 2000) |
| "The efficacy of labetalol in lowering blood pressure was assessed in 18 patients with chronic renal failure and hypertension." | 3.66 | Labetalol in the treatment of hypertensive renal patients. ( Craswell, PW; De Voss, K; Williams, JG, 1978) |
| "Hydralazine is an effective antihypertensive drug which acts by vasodilatation." | 1.40 | Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis. ( Chan, JC; Yap, DY; Yeung, CK, 2014) |
| "Treatment with losartan, captopril, and the TRx prevented the rhEPO-induced increased in systolic BP." | 1.33 | Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. ( Agharazii, M; Larivière, R; Lebel, M; Rodrigue, ME, 2006) |
| "Treatment with captopril also reduced the development of glomerular sclerosis." | 1.29 | Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats. ( Bogdanovic, G; Djukanovic, L; Jovanovic, D; Kartaljevic, G; Starcevic, A; Susic, D; Varagic, J, 1994) |
| "Enalapril treatment significantly reduced proteinuria (731 +/- 23 vs." | 1.29 | Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats. ( Baba, N; Sakemi, T, 1993) |
| "Captopril was also able to reduce the proteinuria of non-diabetic glomerular origin." | 1.28 | Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans. ( Alcazar, JM; Gutierrez-Millet, V; Oliet, A; Praga, M; Rodicio, JL; Ruilope, LM, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (68.18) | 18.7374 |
| 1990's | 7 (15.91) | 18.2507 |
| 2000's | 5 (11.36) | 29.6817 |
| 2010's | 2 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JC | 1 |
| Yap, DY | 1 |
| Yeung, CK | 1 |
| Monajemzadeh, M | 1 |
| Tayari, N | 1 |
| Najafi, M | 1 |
| Madani, A | 1 |
| Mahjoub, F | 1 |
| Esfahani, ST | 1 |
| Ataei, N | 1 |
| Ashtiani, MT | 1 |
| Mohseni, P | 1 |
| Shams, S | 1 |
| Wen, YK | 1 |
| Wen, KI | 1 |
| LICHTIG-DINULESCU, E | 1 |
| BOROS, I | 1 |
| Lebel, M | 1 |
| Rodrigue, ME | 1 |
| Agharazii, M | 1 |
| Larivière, R | 1 |
| Herrera, J | 1 |
| Chávez, M | 1 |
| Marín, C | 1 |
| Mattar, AL | 1 |
| Machado, FG | 1 |
| Fujihara, CK | 1 |
| Malheiros, DM | 1 |
| Zatz, R | 1 |
| Thiele, KG | 1 |
| Muehrcke, RC | 1 |
| Berning, H | 1 |
| Prichard, BN | 1 |
| Holt, RJ | 1 |
| Gaskins, JD | 1 |
| Maeda, T | 1 |
| Onoyama, K | 1 |
| Omae, T | 1 |
| Fujimi, S | 1 |
| Goldberg, AP | 1 |
| Hagberg, J | 1 |
| Delmez, JA | 1 |
| Carney, RM | 1 |
| McKevitt, PM | 1 |
| Ehsani, AA | 1 |
| Harter, HR | 1 |
| Nakamura, M | 1 |
| Suzuki, H | 1 |
| Ohno, Y | 1 |
| Ohishi, A | 1 |
| Yamakawa, H | 1 |
| Okada, H | 1 |
| Saruta, T | 1 |
| Djukanovic, L | 1 |
| Susic, D | 1 |
| Jovanovic, D | 2 |
| Varagic, J | 1 |
| Starcevic, A | 1 |
| Kartaljevic, G | 1 |
| Bogdanovic, G | 1 |
| Sakemi, T | 1 |
| Baba, N | 1 |
| Nakamura, T | 2 |
| Obata, J | 1 |
| Kimura, H | 1 |
| Ohno, S | 1 |
| Yoshida, Y | 2 |
| Kawachi, H | 2 |
| Shimizu, F | 2 |
| Obata, JE | 1 |
| Onitsuka, M | 1 |
| Shimada, Y | 1 |
| Williams, JG | 1 |
| De Voss, K | 1 |
| Craswell, PW | 1 |
| Swartz, CD | 1 |
| Kim, KE | 1 |
| Nolph, KD | 1 |
| Ghods, AJ | 1 |
| Van Stone, J | 1 |
| Brown, PA | 1 |
| Talseth, T | 1 |
| Makó, J | 1 |
| Potyondi, M | 1 |
| Wight, JP | 1 |
| Bassett, AH | 1 |
| Hutchesson, A | 1 |
| Thurrell, W | 1 |
| el Nahas, AM | 1 |
| Rodicio, JL | 2 |
| Alcazar, JM | 2 |
| Ruilope, LM | 2 |
| Praga, M | 1 |
| Oliet, A | 1 |
| Gutierrez-Millet, V | 1 |
| Groth, H | 1 |
| Vetter, H | 1 |
| Achermann, R | 1 |
| Kuhlmann, U | 1 |
| Siegenthaler, W | 1 |
| Vetter, W | 1 |
| Fritel, D | 1 |
| Baglin, A | 1 |
| Rahn, KH | 1 |
| Zimmerman, SW | 1 |
| Bergin, JJ | 1 |
| Siegler, RL | 1 |
| Fillastre, JP | 1 |
| Malandain, M | 1 |
| Gray, H | 1 |
| Dubois, D | 1 |
| Limas, CJ | 1 |
| Freis, ED | 2 |
| Rorive, G | 1 |
| Fishback, DB | 1 |
| Dzúrik, R | 1 |
| Reznícek, J | 1 |
| Krídl, J | 1 |
| Woods, JW | 1 |
| Blythe, WB | 1 |
| Huffines, WD | 1 |
| Tucker, RM | 1 |
| Hunt, JC | 1 |
| Brodwall, EK | 1 |
| Myhre, E | 1 |
| Stenbaek, O | 1 |
| Hirasawa, Y | 1 |
| Omori, H | 1 |
| Takahashi, Y | 1 |
| Imai, H | 1 |
| Takahashi, S | 1 |
| Nestor, G | 1 |
| Beroniade, V | 1 |
| Tutunaru, M | 1 |
| Richet, G | 1 |
| Ducrot, H | 1 |
| Hamburger, J | 1 |
| Legrain, M | 1 |
| Maxwell, M | 1 |
| Péquignot, MH | 1 |
| Vidt, DG | 1 |
3 reviews available for hydralazine and Chronic Kidney Failure
| Article | Year |
|---|---|
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
[Long-term dialysis and its problems: hypertension].
Topics: Humans; Hydralazine; Hypertension, Renal; Japan; Kidney Failure, Chronic; Propranolol; Renal Dialysi | 1980 |
Recent advances in the medical and surgical treatment of hypertension.
Topics: Adrenocortical Hyperfunction; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Ethacryni | 1968 |
2 trials available for hydralazine and Chronic Kidney Failure
| Article | Year |
|---|---|
Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1990 |
[Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide].
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydralazine; Hyperten | 1985 |
39 other studies available for hydralazine and Chronic Kidney Failure
| Article | Year |
|---|---|
Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis.
Topics: Aged; Female; Humans; Hydralazine; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulato | 2014 |
Pseudomelanosis duodeni in a child with chronic renal failure.
Topics: Child; Female; Humans; Hydralazine; Kidney Failure, Chronic; Kidney Transplantation; Melanosis; Neph | 2008 |
An unusual cause of non-infectious peritonitis in a peritoneal dialysis patient.
Topics: Antihypertensive Agents; Arthralgia; Female; Humans; Hydralazine; Kidney Failure, Chronic; Middle Ag | 2014 |
[Acute renal insufficiency during hydrazinophthalazine therapy of chronic renal insufficiency].
Topics: Acute Kidney Injury; Humans; Hydralazine; Kidney Failure, Chronic; Renal Insufficiency, Chronic | 1957 |
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihype | 2006 |
Transient improvement of hypertension-induced chronic renal failure with mycophenolate mofetil treatment.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; | 2006 |
Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Disease Models, Animal; D | 2007 |
[Kidney diseases caused by drugs].
Topics: Acute Kidney Injury; Adult; Anemia; Arthritis, Rheumatoid; Dextrans; Drug-Related Side Effects and A | 1967 |
Pharmacokinetics of hydralazine and the first pass effect.
Topics: Humans; Hydralazine; Intestinal Absorption; Intestinal Mucosa; Kidney; Kidney Failure, Chronic; Kine | 1983 |
The metabolic and psychological effects of exercise training in hemodialysis patients.
Topics: Adult; Anemia; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Cholesterol; Female; Follow-U | 1980 |
Oral calcium carbonate administration ameliorates the progression of renal failure in rats with hypertension.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Calcium Carbonate; Desoxycorticosterone; Doxorubi | 1995 |
Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Captopril; Doxorubicin; Female; Glomerulonephritis; Hematocrit | 1994 |
Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats.
Topics: Animals; Antihypertensive Agents; Cholesterol; Drug Therapy, Combination; Enalapril; Hydralazine; Hy | 1993 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 1999 |
Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Topics: Actins; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Creatinine; Dihydropyridines | 2000 |
Labetalol in the treatment of hypertensive renal patients.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydral | 1978 |
Management of hypertension in the patient with chronic renal disease.
Topics: Blood Pressure; Diuretics; Glomerular Filtration Rate; Guanethidine; Humans; Hydralazine; Hypertensi | 1978 |
The effects of intraperitoneal vasodilators on peritoneal clearances.
Topics: Capillaries; Creatinine; Diazoxide; Humans; Hydralazine; Isoproterenol; Kidney Failure, Chronic; Met | 1976 |
Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.
Topics: Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Half-Life; Humans; Hydralazine | 1976 |
Use of Tensiomin in hypertensive patients with impaired renal function.
Topics: Adult; Captopril; Creatinine; Humans; Hydralazine; Hypertension; Kidney; Kidney Failure, Chronic; Mi | 1992 |
Effect of antihypertensive therapy in experimental chronic renal failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dietary Proteins; Heart; Hydralazine; Kidney Failu | 1991 |
Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1989 |
Refractory hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Chronic Disease; Diazoxide; Drug Combinations; Drug R | 1973 |
[The treatment of arterial hypertension associated with renal insufficiency].
Topics: Clonidine; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Kidney F | 1973 |
[Differential therapeutic principles in the drug therapy of high blood pressure].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Cardiac Vol | 1974 |
Heparin therapy for the renal disease of malignant hypertension.
Topics: Adult; Anemia, Hemolytic; Creatinine; Dipyridamole; Female; Guanethidine; Hematoma; Heparin; Humans; | 1974 |
Malignant hypertension in children; a patient treated with bilateral nephrectomy.
Topics: Blood Pressure; Child; Creatinine; Female; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; H | 1974 |
[Treatment of malignant nephroangiosclerosis with diazoxide].
Topics: Diazoxide; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension, Malignant; Injections, Int | 1972 |
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Evaluation Studies as Topic; Female; Follow-Up Studi | 1973 |
[Hypertension of renal origin].
Topics: Clonidine; Diet, Sodium-Restricted; Glomerulonephritis; Humans; Hydralazine; Hypertension, Renal; Ki | 1973 |
Fluorescein circulation time and the treatment of hypertension in the aged.
Topics: Adult; Age Factors; Aged; Blood Circulation Time; Blood Pressure; Carbamates; Ethacrynic Acid; Femal | 1973 |
[Dihydralazin treatment of hypertension during hemodialysis].
Topics: Humans; Hydralazine; Hypertension, Renal; Injections, Intravenous; Kidney Failure, Chronic; Renal Di | 1973 |
Hypertension: challenge in preventive medicine.
Topics: Aged; Aneurysm; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Drug Therap | 1973 |
Management of malignant hypertension complicated by renal insufficiency. A follow-up study.
Topics: Adult; Aged; Arteries; Autopsy; Benzothiadiazines; Diuretics; Drug Therapy, Combination; Female; Fol | 1974 |
[Treatment of hypertension in renal failure].
Topics: Humans; Hydralazine; Hypertension, Renal; Kidney Failure, Chronic; Methyldopa; Water-Electrolyte Bal | 1972 |
[Chronic kidney failure].
Topics: Adult; Blood Urea Nitrogen; Diet Therapy; Dihydroxyphenylalanine; Humans; Hydralazine; Hypertension, | 1971 |
[Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidn | 1970 |
[May medical therapy of arterial hypertension by used in patients with renal failure?].
Topics: Antihypertensive Agents; Diazoxide; Drug Tolerance; Guanethidine; Humans; Hydralazine; Hypertension; | 1968 |
An approach to the medical treatment of hypertension in the aged.
Topics: Age Factors; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Diuretics; | 1969 |